Related Experiment Videos

14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation

S R Datta1, A Katsov, L Hu

  • 1Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Molecular Cell
|August 19, 2000
PubMed

Insights

Survival signals phosphorylate the proapoptotic protein BAD, inactivating it and promoting cell survival. This process involves sequential phosphorylation events and 14-3-3 protein recruitment, revealing a key mechanism in apoptosis regulation.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The Bcl-2 family regulates apoptosis, with prodeath members interacting with prosurvival members via their BH3 domain.
  • Dysregulation of apoptosis is implicated in various diseases, including cancer and neurodegeneration.

Purpose of the Study:

  • To elucidate the mechanism by which survival signals inactivate the proapoptotic protein BAD.
  • To investigate the role of phosphorylation in regulating BAD activity and its interaction with prosurvival Bcl-2 proteins.

Main Methods:

  • Phosphorylation site analysis of the BAD protein.
  • Investigation of protein-protein interactions between BAD and Bcl-2 family members.
  • Assessment of the role of 14-3-3 proteins in BAD regulation.

Main Results:

  • Survival factors induce phosphorylation of BAD at Ser-155 within its BH3 domain.
  • Phosphorylation at Ser-155 requires prior phosphorylation at Ser-136, which recruits 14-3-3 proteins.
  • 14-3-3 proteins enhance accessibility of Ser-155 to kinases, and Ser-155 phosphorylation disrupts BAD binding to prosurvival Bcl-2 proteins, promoting cell survival.

Conclusions:

  • Survival signals inactivate proapoptotic BAD through sequential phosphorylation events.
  • 14-3-3 proteins act as cofactors in regulating these sequential phosphorylation events.
  • This mechanism provides a novel target for therapeutic interventions aimed at modulating apoptosis.

Related Concept Videos